Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Solid Biosciences Inc (SLDB)

Solid Biosciences Inc (SLDB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 217,609
  • Shares Outstanding, K 38,379
  • Annual Sales, $ 0 K
  • Annual Income, $ -96,020 K
  • 60-Month Beta 1.87
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.03
Trade SLDB with:

Options Overview Details

View History
  • Implied Volatility 101.36% ( +67.01%)
  • Historical Volatility 80.92%
  • IV Percentile 38%
  • IV Rank 12.61%
  • IV High 770.61% on 10/17/23
  • IV Low 4.77% on 09/26/23
  • Put/Call Vol Ratio 17.82
  • Today's Volume 320
  • Volume Avg (30-Day) 129
  • Put/Call OI Ratio 0.71
  • Today's Open Interest 561
  • Open Int (30-Day) 1,177

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.66
  • Number of Estimates 6
  • High Estimate -0.55
  • Low Estimate -0.72
  • Prior Year -1.25
  • Growth Rate Est. (year over year) +47.20%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.21 +18.62%
on 06/26/24
8.71 -29.05%
on 06/13/24
-2.08 (-25.18%)
since 05/31/24
3-Month
5.21 +18.62%
on 06/26/24
12.95 -52.28%
on 04/04/24
-6.26 (-50.32%)
since 04/01/24
52-Week
1.81 +241.44%
on 10/30/23
15.05 -58.94%
on 03/28/24
+0.94 (+17.94%)
since 06/30/23

Most Recent Stories

More News
Are Gene Therapy Stocks The Market's Next Big Winners?

Biotechs Sarepta and BioMarin are among companies advancing cutting-edge gene therapies, although those treatments can come with a $2 million or more price.

SRPT : 156.96 (-0.66%)
BMRN : 82.44 (+0.13%)
BIIB : 232.43 (+0.26%)
CRSP : 53.93 (-0.15%)
EDIT : 4.63 (-0.86%)
NTLA : 22.41 (+0.13%)
NVS : 106.55 (+0.08%)
ORTX : 16.70 (+0.30%)
REGN : 1,052.54 (+0.14%)
SLDB : 6.13 (+8.11%)
BLUE : 0.9688 (-1.56%)
SOLID BIOSCIENCES INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Solid Biosciences Inc. - SLDB

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Solid Biosciences Inc. (“the Company”)...

SLDB : 6.13 (+8.11%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JVA, SLDB, FCRD, SPNE

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

JVA : 2.02 (-13.68%)
SLDB : 6.13 (+8.11%)
FCRD : 4.54 (-3.61%)
SPNE : 9.54 (+8.29%)
SOLID BIOSCIENCES INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Solid Biosciences Inc. - SLDB

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Solid Biosciences Inc. (“the Company”)...

SLDB : 6.13 (+8.11%)
SLDB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Solid Biosciences Inc. Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Solid Biosciences Inc. (NASDAQ: SLDB) and AavantiBio, Inc. is fair to Solid shareholders.

SLDB : 6.13 (+8.11%)
Solid Biosciences Provides Second Quarter 2022 Business Update and Financial Results

- Transition to transient transfection-based manufacturing process continues for SGT-001; Company expects to continue dosing patients in 2023 - -...

SLDB : 6.13 (+8.11%)
Solid Biosciences Reports Inducement Grant to New Senior Vice President, Quality

CAMBRIDGE, Mass., June 02, 2022 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful...

SLDB : 6.13 (+8.11%)
Solid Biosciences Announces Updated Corporate Strategy to Develop SGT-001 and SGT-003 Pipeline Programs for Patients with Duchenne Muscular Dystrophy

- IGNITE DMD functional and durability patient data support advancement of SGT-001; Program transitioning to a commercially scaled transient...

SLDB : 6.13 (+8.11%)
Solid Biosciences Reports Fourth Quarter and Full-Year 2021 Financial Results and 2-Year Efficacy and Safety Data from the Ongoing Phase I/II IGNITE DMD Clinical Trial of SGT-001

- 2-year data from first three patients in the high dose (2E14 vg/kg) cohort suggest sustained or improved motor function, pulmonary function and...

SLDB : 6.13 (+8.11%)
Solid Biosciences to Participate at the SVB Leerink 11th Annual Global Healthcare Conference

CAMBRIDGE, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful...

SLDB : 6.13 (+8.11%)

Business Summary

Solid Biosciences LLC is a life science company. It focuses on developing therapies for Duchenne muscular dystrophy. The company is engaged in developing gene therapies, disease modifying therapies and assistive devices, all targeting the various facets of the DMD. Its product candidate includes SGT-001,...

See More

Key Turning Points

3rd Resistance Point 6.44
2nd Resistance Point 6.24
1st Resistance Point 5.95
Last Price 6.13
1st Support Level 5.46
2nd Support Level 5.26
3rd Support Level 4.97

See More

52-Week High 15.05
Fibonacci 61.8% 9.99
Fibonacci 50% 8.43
Fibonacci 38.2% 6.87
Last Price 6.13
52-Week Low 1.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar